Cover Image
Market Research Report

Specialty Generic Pharmaceuticals Market, By Types (Injectable, Oral Drugs and Others), by Indication, by End Use And Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

Published by AnalystView Market Insights Product code 737946
Published Content info 102 Pages
Delivery time: 1-2 business days
Price
Back to Top
Specialty Generic Pharmaceuticals Market, By Types (Injectable, Oral Drugs and Others), by Indication, by End Use And Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
Published: September 13, 2017 Content info: 102 Pages
Description

Report Hightlights

The specialty generic pharmaceuticals market is estimated to represent a global market of USD 28.7 billion by 2016 with growth rate of 20.8%. Spending on specialty generic pharmaceuticals market is growing rapidly over past few years owing to the growing demand for cost effective therapeutics for various disease indications. It is analyzed that the rise in cost of specialty therapeutic treatments were the primary driver for the growth in spending compared to the increased utilization of specialty generics. The costs for specialty therapeutics are often high compared to other treatment options. However, these drugs are exhibit life-changing potential and offer high effectiveness in treatment of life threatening chronic conditions. Factors such as rising number of off-patent specialty drugs, increasing demand for generic specialty drugs due to low cost.

Drug spending on specialty generics is also expected to rise owing to the rise in prevalence of chronic diseases such as inflammatory conditions, multiple sclerosis, oncology and others drives the market growth. According to the Health of America, spending will increase at a higher growth rate for specialty pharmaceuticals. This spending is expected to cover by health insurance under the pharmacy benefits rather than medical benefits. However, advent of biologic therapeutics i.e. biosimilar is expected to cut cost of many commercially available generic therapeutics. Biosimilars are less costly and used treat a range of diseases including rheumatoid arthritis, cancer, diabetes and others.

The global specialty generic pharmaceutic market is categorized in terms of injectables, oral drugs and others. Among which, oral and self-injectable specialty therapeutics has been increasing owing to the technological advancements. Injectable generic therapeutics is considered to be the fast catching market segment, growing constantly over the forecast period. Injectable generics for oncology treatment is widely in demand across the globe. Therapeutics such as Avastin(Bevacizumab), Taxol(Pacitaxel), Doxil(Doxorubicin), Paraplatin(Carboplatin), Sutent(Sunitinib), Votrient(Pazopanib) and others are some of the injectable oncology therapeutics.

Based on indication, the market is divided as Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, and Others. Of which, we noticed that the growth of specialty genetics spending for hepatitis indication is increasing very rapidly over the forecast year. Growth of this segment is majorly attributed to the high demand coupled with increasing incidence of this disease. Introduction of novel generic therapeutics is also considered to be the primary for this market growth. End use segment is covered under Specialty pharmacies, Retail pharmacies and Hospital pharmacies. Specialty pharmacies accounted for the largest share of the global market, captured around USD 21.6 billion in 2016 and is expected to dominate the market over the forecast period.

Key companies that spend on the specialty generic drugs have increased at significant rate compared to the traditional pharmaceuticals. As per the estimates, around USD 87 billion was spent on specialty therapeutics by 2012 and the spending could reach to around USD 350 billion by 2020 (around increase by 26%). Companies such as Teva Generics, Mylan N.V., Pfizer, Inc. and Novartis AG are on forefront of specialty generic pharmaceuticals market. These companies are engaged in extensive research and development activities to develop novel generic therapeutics to enhance their market share.

Pfizer, Inc. captured significant share of the market in 2016. The company has adopted advanced technologies and formularies for development of high quality generics. Moreover, the company is highly inclined toward maintaining competition in the market as well as delivering economic value to customers and satiate unmet demands. One of the major deals of Pfizer, Inc. was the acquisition of Hospira, Inc. in 2015, which resulted in capturing of greater share of the generic injectables market space.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

Historical Year - 2014 & 2015

Base Year - 2015

Estimated Year - 2016

Projected Year - 2025

TARGET AUDIENCE

Traders, Distributors, And Suppliers

Manufacturers

Hospitals

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT:

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPES

Injectable

Oral

Others

MARKET, BY INDICATION

Oncology

Inflammatory

Multiple sclerosis

Hepatitis C

Others

MARKET, BY END USE

Specialty Pharmacies

Retail Pharmacies

Hospital Pharmacies

MARKET, BY REGION

North America

Europe

Asia Pacific

Rest of the World

MARKET, BY COUNTRY

Further Breakdown of The North America Market

U.S.

Canada

Further Breakdown of The Europe Market

Germany

France

Rest of Europe

Further Breakdown of The APAC Market

India

China

Rest of APAC

Further Breakdown of The Rest of the World Market

Middle East and Africa

Latin America

Table of Contents
Product Code: AV101

TABLE OF CONTENTS

SPECIALTY GENERIC PHARMACEUTICALS MARKET OVERVIEW

Study Scope

Base Year

Assumption and Methodology

EXECUTIVE SUMMARY

Key Market Facts

Geographical Scenario

Companies in the Market

SPECIALTY GENERIC PHARMACEUTICALS KEY MARKET TRENDS

Market Drivers

Impact Analysis of Market Drivers

Market Restraints

Impact Analysis of Market Restraints

Market Opportunities

Market Future Trends

SPECIALTY GENERIC PHARMACEUTICALS INDUSTRY STUDY

Company Activity Analysis

Regulatory Framework Analysis

Pipeline Analysis

Value Chain Analysis

SPECIALTY GENERIC PHARMACEUTICALS MARKET LANDSCAPE

Market Share Analysis

Key Innovators

SPECIALTY GENERIC PHARMACEUTICALS MARKET - BY TYPES:

Overview

Injectable

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Oral

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Others

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

SPECIALTY GENERIC PHARMACEUTICALS MARKET - BY INDICATION:

Overview

Oncology

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Inflammatory conditions

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Multiple sclerosis

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Hepatitis C

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Others

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

SPECIALTY GENERIC PHARMACEUTICALS MARKET - BY END USE:

Overview

Specialty pharmacies

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Retail pharmacies

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Hospital pharmacies

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

SPECIALTY GENERIC PHARMACEUTICALS MARKET- BY GEOGRAPHY

Introduction

North America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

S.

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Canada

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

France

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Germany

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Asia Pacific (APAC)

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

China

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

India

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of APAC

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of the World

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Latin America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Middle East and Africa

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

KEY VENDOR ANALYSIS

Teva Pharmaceuticals, Inc.

Company Overview

SWOT Analysis

Key Developments

Valeant Pharmaceuticals

Company Overview

SWOT Analysis

Key Developments

Sun Pharmaceuticals

Company Overview

SWOT Analysis

Key Developments

Mylan N.V.

Company Overview

SWOT Analysis

Key Developments

Pfizer, Inc.

Company Overview

SWOT Analysis

Key Developments

Novartis AG

Company Overview

SWOT Analysis

Key Developments

360 DEGREE ANALYSTVIEW

APPENDIX

Research Methodology

Abbreviations

Disclaimer

Contact Us

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

Understanding of the strategies that are being adopted by the key players in this market to stay competitive

Extensive analysis of the key players dominating the competitive landscape of this market

In-depth analysis of the key factors are propelling the growth of the global market

Detailed analysis of the geographic region that will witness the strongest growth

Granular analysis of the current market scenario and the expected market grow

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PESTLE Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Specialty Generic Pharmaceuticals Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • Figure 10 Specialty Generic Pharmaceuticals Market, by Types, 2014 - 2025 (USD Million)
  • Figure 11 Specialty Generic Pharmaceuticals Market, by Indication, 2014 - 2025 (USD Million)
  • Figure 12 Specialty Generic Pharmaceuticals Market, by End Use, 2014 - 2025 (USD Million)
  • Figure 13 Specialty Generic Pharmaceuticals Market, by Geography, 2014 - 2025 (USD Million)
  • Table 14 North America Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 15 U.S. Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 16 Canada Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 17 Europe Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 18 France Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 19 Germany Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 20 Asia Pacific Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 21 China Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 22 India Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 23 Latin America Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)
  • Table 24 MEA Specialty Generic Pharmaceuticals Market, 2014 - 2025 (USD Million)

List of Figures

  • Figure 1 Research Methdology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Specialty Generic Pharmaceuticals Market, by Types, 2014 - 2025 (USD Million)
  • Figure 7 Specialty Generic Pharmaceuticals Market, by Indication, 2014 - 2025 (USD Million)
  • Figure 8 Specialty Generic Pharmaceuticals Market, by End Use, 2014 - 2025 (USD Million)
  • Figure 9 Specialty Generic Pharmaceuticals Market, by Geography, 2014 - 2025 (USD Million)
Back to Top